4.6 Article

3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma

Related references

Note: Only part of the references are listed.
Review Oncology

Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature

Chakrabhavi Dhananjaya Mohan et al.

Summary: Signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor involved in various human malignancies. Its activation promotes tumor progression, while inhibiting STAT3 signaling can effectively suppress tumor growth. This review provides a comprehensive overview of the mechanisms of STAT3 signal transduction, its negative regulators, the role of STAT3 in oncogenesis, and the inhibition of STAT3 signaling by natural compounds with potential anti-tumor activity.

SEMINARS IN CANCER BIOLOGY (2022)

Review Biochemistry & Molecular Biology

The multifaceted antineoplastic role of pyrimethamine against human malignancies

Shanaya Ramchandani et al.

Summary: Cancer is the second leading cause of death worldwide, and finding new therapeutic agents or repurposing existing drugs is crucial. Pyrimethamine has shown promising anticancer potential and has a good safety profile. It inhibits oncogenic proteins and works synergistically with other drugs to induce apoptosis in tumor cells. Clinical trial results also demonstrate its effectiveness in treating chronic lymphocytic leukemia.

IUBMB LIFE (2022)

Article Oncology

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

Dharambir Kashyap et al.

Summary: The application of natural product-based nanoformulations in the treatment of various human diseases, such as cancer, is a growing field. Nanotechnology in cancer therapeutics has overcome the limitations of conventional drug delivery systems, with promising results in targeting tumor cells and reducing side effects. The integration of phytotherapy and nanotechnology in clinical settings may lead to better pharmacological responses and improved clinical outcomes for patients.

SEMINARS IN CANCER BIOLOGY (2021)

Review Chemistry, Medicinal

The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy

Manoj Garg et al.

Summary: The review discusses the regulation of STAT3 signaling and its association with the development of both solid and hematological malignancies. It also mentions various ways to target oncogenic STAT3 signaling using small molecules derived from natural products.

MEDICINAL RESEARCH REVIEWS (2021)

Article Biochemistry & Molecular Biology

Brucein D modulates MAPK signaling cascade to exert multi-faceted anti-neoplastic actions against breast cancer cells

Chakrabhavi Dhananjaya Mohan et al.

Summary: Research has shown that brucein D (BD) has anti-cancer effects on breast cancer cells, inducing apoptosis, impacting cell invasion and migration abilities, and acting through modulation of the MAPK signaling pathway.

BIOCHIMIE (2021)

Article Oncology

Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway

Loukik Arora et al.

Summary: STAT3 is a major oncogenic transcription factor that is constitutively activated in various human cancers, including HCC and MM. Tris DBA, a palladium-based compound, has shown inhibitory efficacy on STAT3 signaling in preclinical cancer models by elevating the expression of SHP2 and inhibiting cell proliferation, migration, invasion, and tumor metastasis. This study provides evidence for the potential consideration of Tris DBA in clinical trials for cancer treatment.

CANCERS (2021)

Review Oncology

Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways

Mahshid Deldar Abad Paskeh et al.

Summary: This review discusses the role of Wnt signaling in hepatocellular carcinoma (HCC), including its promotion of HCC progression, impact on therapy response, and regulation of drug resistance and immune resistance mechanisms. Research shows that beta-catenin signaling in HCC cells can enhance cancer stem cell features, promote growth, and inhibit apoptosis, thus accelerating cancer development.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Article Plant Sciences

Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine

Young Yun Jung et al.

Summary: Leelamine (LEE) inhibits STAT3 phosphorylation and up-stream signaling molecules, leading to cell cycle arrest and enhanced apoptosis in multiple myeloma cells. When used in combination with bortezomib, it synergistically enhances apoptotic actions against MM cells.

PHYTOMEDICINE (2021)

Review Biochemistry & Molecular Biology

Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma

Chakrabhavi Dhananjaya Mohan et al.

Summary: Hepatocellular carcinoma (HCC) is a deadly cancer with a high mortality rate, and STAT3 plays a crucial role in its development by regulating various genes and cellular functions. Long noncoding RNAs (lncRNAs) influence STAT3 signaling through diverse molecular mechanisms, impacting the pathogenesis and progression of HCC.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Biochemistry & Molecular Biology

Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma

Chakrabhavi Dhananjaya Mohan et al.

Summary: Crocetin inhibits STAT3 activation in HCC cells and affects the expression of multiple genes associated with cancer, thereby suppressing cell proliferation and invasive capacity.

IUBMB LIFE (2021)

Review Biochemistry & Molecular Biology

The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma

Xuejiao Chen et al.

BIOMOLECULES (2020)

Article Oncology

IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma

Phyllis S. Y. Chong et al.

CANCER RESEARCH (2019)

Review Cell Biology

Nanoparticles Targeting STATs in Cancer Therapy

Milad Ashrafizadeh et al.

CELLS (2019)

Article Biochemistry & Molecular Biology

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma

Jong Hyun Lee et al.

BIOMOLECULES (2019)

Article Biochemistry & Molecular Biology

Casticin inhibits growth and enhances ionizing radiation-induced apoptosis through the suppression of STAT3 signaling cascade

Jong Hyun Lee et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors

Matilda Lee et al.

REDOX BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development

Jacopo Sgrignani et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Pharmacology & Pharmacy

Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade

Young Yun Jung et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Oncology

Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells

Chakrabhavi Dhananjaya Mohan et al.

FRONTIERS IN ONCOLOGY (2018)

Article Multidisciplinary Sciences

Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation

Vijay Pandey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Pharmacology & Pharmacy

N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway

Chakrabhavi Dhananjaya Mohan et al.

FRONTIERS IN PHARMACOLOGY (2018)

Review Immunology

Mechanisms and consequences of Jak-STAT signaling in the immune system

Alejandro V. Villarino et al.

NATURE IMMUNOLOGY (2017)

Article Chemistry, Multidisciplinary

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer

Anusha Sebastian et al.

ACS OMEGA (2016)

Article Chemistry, Medicinal

Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma

Mahabaleshwaraiah Neelgundmath et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Chemistry, Medicinal

Synthesis and characterization of novel oxazines and demonstration that they specifically target cyclooxygenase 2

V. Srinivas et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Biotechnology & Applied Microbiology

Tyrosine 705 Phosphorylation of STAT3 Is Associated with Phenotype Severity in TGFβ1 Transgenic Mice

Eleonora Guadagnin et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

6-Shogaol Exerts Anti-Proliferative and Pro-Apoptotic Effects Through the Modulation of STAT3 and MAPKs Signaling Pathways

Sung-Moo Kim et al.

MOLECULAR CARCINOGENESIS (2015)

Article Biochemistry & Molecular Biology

Synthesis, Structural Characterization, and Biological Activity Studies of Ni(II) and Zn(II) Complexes

Palakuri Kavitha et al.

BIOINORGANIC CHEMISTRY AND APPLICATIONS (2014)

Article Biochemistry & Molecular Biology

Formylchromone exhibits salubrious effects against nitrosodiethylamine mediated early hepatocellular carcinogenesis in rats

M. Ilamathi et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2014)

Review Oncology

STAT3 Target Genes Relevant to Human Cancers

Richard L. Carpenter et al.

CANCERS (2014)

Review Oncology

STAT3 in hepatocellular carcinoma: new perspectives

Jasmin Svinka et al.

HEPATIC ONCOLOGY (2014)

Article Chemistry, Medicinal

3-Formylchromones: Potential antiinflammatory agents

Khalid M. Khan et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Schiff bases of 3-formylchromone as thymidine phosphorylase inhibitors

Khalid Mohammed Khan et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2009)